Western Pacific Region Index Medicus

Erratum: Author correction to "YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer" Acta Pharmaceutica Sinica B 12 (2022) 2845-2858.

Author: Fangfang LAI ¹ ; Ming JI ¹ ; Lei HUANG ¹ ; Yunchen WANG ¹ ; Nina XUE ¹ ; Tingting DU ¹ ; Kai DONG ² ; Xiaoqing YAO ² ; Jing JIN ¹ ; Zhiqiang FENG ³ ; Xiaoguang CHEN ¹
Author Information

1. Department of Pharmacology, State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
2. Tianjin Chase Sun Pharmaceutical Co., Ltd., Tianjin 300170, China.
3. Department of Pharmacochemistry, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Publication Type:Published Erratum
From: Acta Pharmaceutica Sinica B 2023;13(7):3178-3179
CountryChina
Language:English
Abstract: [This corrects the article DOI: 10.1016/j.apsb.2022.02.031.].